The effectiveness of amiridin in senile dementia of the Alzheimer's type.
Bukatina
E E
EE
Moscow Scientific Research Institute of Psychiatry, RFSFR Ministry of Health.
Grigor'eva
I V
IV
Sokol'chik
E I
EI
D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000188:drug therapy* / Q000523:psychology; D000634:Aminoquinolines / Q000009:adverse effects / Q000627:therapeutic use*; D002800:Cholinesterase Inhibitors; D003071:Cognition / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales; D011619:Psychotropic Drugs / Q000009:adverse effects / Q000627:therapeutic use*; D013060:Speech / Q000187:drug effects
D000634:Aminoquinolines; D002800:Cholinesterase Inhibitors; D011619:Psychotropic Drugs; C049860:amiridine